A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer’s Disease: Establishment by Using Acitretin as a Model Drug
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer’s Disease: Establishment by Using Acitretin as a Model Drug
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 3, Pages e91003
Publisher
Public Library of Science (PLoS)
Online
2014-03-08
DOI
10.1371/journal.pone.0091003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
- (2013) Stephanie JB Vos et al. LANCET NEUROLOGY
- Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia
- (2013) André Karch et al. PLoS One
- Establishment of a simplified in vitro porcine blood–brain barrier model with high transendothelial electrical resistance
- (2012) Adjanie Patabendige et al. BRAIN RESEARCH
- BACE1 in Alzheimer's disease
- (2012) M. Sathya et al. CLINICA CHIMICA ACTA
- Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
- (2012) Philip T.T. Ly et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation of NMDA Receptors Upregulates A Disintegrin and Metalloproteinase 10 via a Wnt/MAPK Signaling Pathway
- (2012) X.-Z. Wan et al. JOURNAL OF NEUROSCIENCE
- Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors
- (2012) Lars Messing et al. NEUROBIOLOGY OF AGING
- Acitretin, an Enhancer of Alpha-Secretase Expression, Crosses the Blood-Brain Barrier and Is Not Eliminated by P-Glycoprotein
- (2012) David Holthoewer et al. Neurodegenerative Diseases
- The P-glycoprotein multidrug transporter
- (2011) Frances J. Sharom Essays in Biochemistry
- Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell models
- (2011) Kathryn Hatherell et al. JOURNAL OF NEUROSCIENCE METHODS
- Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: Comparison with conventional monocultures
- (2011) Jennifer Kasper et al. Particle and Fibre Toxicology
- Upregulation of the α-secretase ADAM10 - risk or reason for hope?
- (2010) Kristina Endres et al. FEBS Journal
- Mitochondrial dysfunction and Alzheimer's disease
- (2010) Aleksandra Maruszak et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier
- (2009) Birk Poller et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Up-regulation of the α-secretase ADAM10 by retinoic acid receptors and acitretin
- (2009) Frank Tippmann et al. FASEB JOURNAL
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells
- (2008) Sandrine Dauchy et al. BIOCHEMICAL PHARMACOLOGY
- Differential effects of hydrocortisone and TNFα on tight junction proteins in anin vitromodel of the human blood-brain barrier
- (2008) Carola Förster et al. JOURNAL OF PHYSIOLOGY-LONDON
- An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening
- (2008) Maxime Culot et al. TOXICOLOGY IN VITRO
- Pericyte–endothelial cell interaction increases MMP-9 secretion at the blood–brain barrier in vitro
- (2007) Alla Zozulya et al. BRAIN RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started